Product Details
Hemlibra 60 mg / 0.4 mL (emicizumab injection In Pakistan
Hemlibra 60 mg/0.4 mL Injection contains emicizumab, a monoclonal antibody used for routine prevention of bleeding episodes in patients with Hemophilia A, with or without factor VIII inhibitors. It works by mimicking the function of activated factor VIII to support the blood-clotting process. Hemlibra is administered as a subcutaneous injection under the supervision of a qualified healthcare professional.
Benefits
-
Helps prevent or reduce the frequency of bleeding episodes in Hemophilia A.
-
Suitable for patients with or without factor VIII inhibitors, as prescribed.
-
Supports routine preventive management of Hemophilia A.
-
Offers a subcutaneous injection option.
-
Can be used in eligible adults and children according to medical advice.
Specifications
-
Product Name: Hemlibra Injection
-
Active Ingredient: Emicizumab
-
Strength: 60 mg/0.4 mL
-
Concentration: 150 mg/mL
-
Dosage Form: Solution for injection
-
Route of Administration: Subcutaneous injection
-
Packaging: Single-dose vial
-
Indication: Prevention of bleeding episodes in Hemophilia A
-
Storage: Refrigerate at 2°C–8°C; protect from light. Do not freeze or shake.
How To Use
-
Use Hemlibra only as prescribed by a qualified healthcare professional.
-
The dose and injection schedule depend on body weight and the prescribed treatment plan.
-
It is administered under the skin, commonly in the abdomen, thigh, or upper outer arm by a caregiver or healthcare professional.
-
Follow the prescribed instructions for preparing and administering the injection.
-
Store the medicine in the refrigerator at 2°C–8°C and keep it in its original carton.
-
Do not reuse the vial or save any unused medicine.
Important: Do not change your dose or schedule without medical advice. Hemlibra may interact dangerously with certain clotting medicines, particularly activated prothrombin complex concentrate (aPCC). Seek medical advice if you experience unusual symptoms or side effects.
Why Choose Hemlibra?
-
A specialized treatment option for Hemophilia A.
-
Helps reduce the frequency of bleeding episodes when used as prescribed.
-
Available in a convenient single-dose vial.
-
Provides a preventive treatment option for eligible patients with or without factor VIII inhibitors.
-
Should be obtained from a reliable, licensed medicine supplier and used under specialist supervision.
